1315 CAPITAL
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
1315 CAPITAL
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2014-01-01
Status:
Active
Contact:
+1 215 662 1315
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Alterna Capital Partners
Alterna invests in Core Capital Assets for the transportation, industrial and energy sectors.
Attain Capital Partners
Attain Capital Partners invests in growth-stage companies in the knowledge economy.
Brain-Too-Free Ventures
Brain-Too-Free Ventures provide inorganic growth capital and shareholder liquidity for rapidly growing, privately-held companies.
Camden Partners
Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.
Country Garden Venture Capital
Country Garden Venture Capital focuses on the four major investment themes of industrial chain, technology, health, and consumption.
Fannin Innovation Studio
Fannin Innovation Studio focuses on commercializing innovation developed in the Texas Medical Center institutions.
Hopewell Ventures
Hopewell Ventures provides equity capital and strategic expertise to high-growth businesses, primarily in the Midwest.
July Ventures
July Ventures provides patient capital and partners with passionate entrepreneurs in building and scaling their businesses.
Nickleby Capital
Nickleby Capital provides investment capital to help accelerate growth in high-potential companies.
RiverGlade Capital
RiverGlade Capital is a growth-oriented private equity firm that invests in healthcare services companies.
Route 66 Ventures
Route 66 Ventures provides venture capital and credit solutions to emerging financial technology and services companies.
Spring Lane Capital
Spring Lane Capital offers a new approach to faster growth for companies that deploy smaller-scale projects and equipment.
Synergy Ventures
Synergy has been actively involved in medical technology and venture capital since 1996.
The Conscious Fund
The Conscious Fund invests in early stage ventures in plant-powered medicine.
Xerox Venture Capital
Xerox Venture Capital Companies whose technology or products are strategically relevant to Xerox.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-30 | Homestead Smart Health Plans | Homestead Smart Health Plans acquired by 1315 Capital | N/A |
| 2021-05-11 | miraDry | miraDry acquired by 1315 Capital | N/A |
| 2019-01-16 | Biocoat | Biocoat acquired by 1315 Capital | N/A |
| 2018-10-17 | Centurion Service Group | Centurion Service Group acquired by 1315 Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | NutriSense | 1315 Capital investment in Series A - NutriSense | 25 M USD |
| 2021-09-01 | Onkos Surgical | 1315 Capital investment in Series C - Onkos Surgical | 22.5 M USD |
| 2019-04-08 | Encore Dermatology | 1315 Capital investment in Debt Financing - Encore Dermatology | 20 M USD |
| 2017-11-09 | Misonix | 1315 Capital investment in Post-IPO Equity - Misonix | 25 M USD |
| 2017-07-21 | Colorescience | 1315 Capital investment in Series C - Colorescience | 15 M USD |
| 2017-04-19 | Onkos Surgical | 1315 Capital investment in Series B - Onkos Surgical | 17.6 M USD |
| 2015-10-31 | JDS Therapeutics LLC | 1315 Capital investment in Private Equity Round - JDS Therapeutics LLC | 16 M USD |
| 2015-10-06 | Onkos Surgical | 1315 Capital investment in Series A - Onkos Surgical | N/A |
More informations about "1315 Capital"
Pharmaceutical Investments | Medical Tech …
Three operating teams contribute their collective experience across subsectors to 1315 Capital. These three teams have built companies from expansion and growth phases to businesses with revenues in excess of $100 million. …See details»
1315 Capital - Crunchbase Investor Profile & Investments
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and …See details»
Financial Portfolio | Partner of Choice - 1315 Capital
1315 Capital has partnered with many healthcare companies that have thrived due to the firm’s valuable industry insight and hands-on approach. Investor Login; Home; ... Specialty clinical …See details»
1315 Capital - Investments, Portfolio & Company Exits - Crunchbase
Sep 30, 2021 1315 Capital 's most notable exits include Colorescience, Interpace Biosciences, and Misonix. 1315 Capital has acquired 5 organizations. Their most recent acquisition was …See details»
1315 Capital Closes Two Funds, Raising over $500 Million to Invest …
Oct 23, 2023 1315 Capital is a private investment firm with over $1 billion of assets under management that provides growth capital to commercial-stage healthcare services, …See details»
1315 Capital Closes Two Funds, Raising over $500 Million to Invest …
The two funds give 1315 Capital the flexibility to invest between $5 million and $40 million in minority or majority transactions. "From the inception of the firm, our goal has been to target …See details»
Pryor Cashman Client 1315 Capital Raises Over $500 …
Oct 25, 2023 Read the full statement from 1315 Capital using the link below. 1315 Capital is represented by Pryor Cashman Partner Robert Friedman, a member of the Corporate Group; Partner Shane Stroud, chair of the Executive …See details»
1315 Capital - Funding, Financials, Valuation & Investors
1315 Capital has raised a total of $650M across 4 funds, their latest being 1315 Capital III. Announced Date . Fund Name . Money Raised . Oct 23, 2023: 1315 Capital III . obfuscated. …See details»
1315 Capital Closes Two Funds | citybiz
Oct 23, 2023 1315 Capital is a private investment firm with over $1 billion of assets under management that provides growth capital to commercial-stage healthcare services, pharmaceutical & medical technology outsourcing, …See details»
Experic Announces Growth Capital Investment Led by 1315 Capital
Oct 29, 2024 Experic is a contract development and manufacturing organization ... 1315 Capital is a private investment firm with over $1 billion of assets under management that provides …See details»
Financial Knowledge | Healthcare Experience | 1315 Capital
Michael Koby co-founded 1315 Capital in 2014, after spending his entire career as a healthcare investor and operator, including experience with more than 25 growth equity investments. Prior …See details»
Experic Announces Growth Capital Investment Led by 1315 Capital
CRANBURY, N.J., October 29, 2024--Experic secures additional investment to enhance manufacturing and CTS capabilities, expand globally, and meet growing biopharma industry …See details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 1315 Capital is a private investment firm with over $1 billion of assets under management that provides growth capital to commercial-stage healthcare services, …See details»
ProSciento Closes Growth Financing from 1315 Capital
Sep 10, 2020 ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis (NASH), diabetes, obesity, and rel. ... About 1315 Capital, LLC.See details»
UPDATED: 1315 Capital closes first healthcare fund, raises $200M
Jun 16, 2016 The fund is led by seasoned healthcare investors and 1315 Capital's co-founders Adele Oliva and Michael Koby, and includes a group of investors, including endowments, …See details»
Investment Leadership | Operating Teams | 1315 Capital
1315 Capital investment partners have been investing exclusively in expansion and growth stage healthcare companies their entire careers, with proven results through multiple market cycles. …See details»
ProSciento Closes Growth Financing from 1315 Capital
SAN DIEGO and PHILADELPHIA, September 10, 2020 /Businesswire/ – ProSciento, Inc., a leading specialty clinical research organization (CRO) focused on non-alcoholic steatohepatitis …See details»
Paris dreams of becoming the capital of positive AI with the ...
21 hours ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»
1315 Capital - Contacts, Employees, Board Members ... - Crunchbase
1315 Capital has 13 current employee profiles, including Co-Founder & Partner Michael Koby. 1315 Capital has 1 board member or advisor, Rick Ferreira. Contacts. Edit Contacts Section. …See details»
Press Release Archives - 1315 Capital
Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the global biopharmaceutical industry, today announced …See details»